{"schema_version":"secwatch.filing_event.v1","accession":"0000874501-25-000131","form_type":"8-K","ticker":"OSG","cik":"0000874501","company_name":"OCTAVE SPECIALTY GROUP INC","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.536817+00:00","generated_at":"2026-05-17T18:42:36.108426+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ambac Q2 total revenue up 8% to $55M; net loss widens to $72.7M as legacy sale nears approval","bullets":["Total P&C premium production surged 110% to $346M, boosted by Beat acquisition.","Cirrata revenue up 148% to $33M; adjusted EBITDA to shareholders rose 28% to $3M.","Everspan combined ratio improved to 107% (down 270 bps) on lower loss ratio of 67.8%.","Net loss from continuing ops to Ambac shareholders $(20.5M) vs $(14.9M) a year ago; adjusted EPS $(0.22).","Wisconsin OCI recommends approval for AAC sale; hearing set Sept 3, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000874501-25-000131","json":"https://secwatch.observer/filing/0000874501-25-000131.json","markdown":"https://secwatch.observer/filing/0000874501-25-000131.md","text":"https://secwatch.observer/filing/0000874501-25-000131.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/874501/000087450125000131/0000874501-25-000131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874501/000087450125000131/ambc-20250807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:42:36.108426+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}